RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Drug Delivery Innovations Driving Improved Patient Compliance
Jul 2011 - 147 pages - $3,835
Eli Lilly Drops Plans to Seek Approval For its Established Drug Alimta as a Treatment For Head And Neck Cancer
Nov 2010 - 5 pages - $500
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Innovations in the Delivery of Cancer Therapies
Jan 2011 - 231 pages - $3,835
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
Oct 2010 - 64 pages - $2,000
Methotrexate (Head and Neck Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 43 pages - $2,000
Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020
Oct 2011 - 43 pages - $2,000
Controlled-release: Players, products & prospects to 2018 (Volume I)
Jun 2009 - 126 pages - $1,040
Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 42 pages - $2,000
Tykerb (Head and Neck Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 40 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Parenteral del
Sustained release del
Therapeutic target
Oncology del
Head and neck cancer del
Development phase
Preregistration del

Browse By

Therapeutic target
Nasopharyngeal cancer
Paranasal sinus cancer
Salivary gland cancer
Thyroid cancer

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us